ParkerVision (PRKR) Enters SPA for 8.14M Common at $1.05/Share
Tweet Send to a Friend
ParkerVision, Inc. (Nasdaq: PRKR) announced the signing of a securities purchase agreement for the sale of 8,139,050 shares of its common stock at a price of $1.05 per share, in a registered offering to certain institutional and other investors.
Upon closing, net proceeds from the sale of the shares, after deducting the placement agent's fees and the other offering expenses, are expected to be approximately $8.4 million. The offering is subject to customary closing conditions and is expected to close on or about April 18, 2012. The Company plans to use the net proceeds from the offering for working capital and for other general corporate purposes, including funding its research, its sales and marketing activities and its infringement litigation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Upon closing, net proceeds from the sale of the shares, after deducting the placement agent's fees and the other offering expenses, are expected to be approximately $8.4 million. The offering is subject to customary closing conditions and is expected to close on or about April 18, 2012. The Company plans to use the net proceeds from the offering for working capital and for other general corporate purposes, including funding its research, its sales and marketing activities and its infringement litigation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Apricus Bio (APRI) Prices 6M Common Stock Offering
- Dean Foods (DF) Completes WhiteWave (WWAV) Spin-Off
- Tempur-Pedic (TPX) is Now 'Tempur Sealy International'
Create E-mail Alert Related Categories
Corporate News, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
